ClinicalTrials.gg
Sign In

Hyperandrogenism clinical trials

The registry lists 81 studies for Hyperandrogenism across more than 10 countries. 22 are recruiting or about to start. 20 of them are mainly about Hyperandrogenism (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Hyperandrogenism studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
37
Recruiting
15
Status unknown
13
Terminated
6
Not yet recruiting
5
Enrolling by invitation
2

Phase

Phase 2
10
Phase 4
9
Early Phase 1
4
Phase 1
3
Phase 3
2

Where

United States
30
Spain
6
Italy
4
Brazil
3
Poland
3
Israel
3

Who runs them

University of Virginia (11) · Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal (3) · AGUNCO Obstetrics and Gynecology Centre (2) · National Institute of Environmental Health Sciences (NIEHS) (2) · Assistance Publique - Hôpitaux de Paris (2) · Royal College of Surgeons, Ireland (2) · Namsos Hospital (1) · Novartis Pharmaceuticals (1)

What is being tested here

Drugs under test in Hyperandrogenism studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Progesterone306
Spironolactone203
Metformin118
Osilodrostat101
Cabergoline101
Bicalutamide101
Magnesium101
Carnitine101
Inositol004
Drospirenone and ethinyl estradiol combination002

Drug classes tested here Mineralocorticoid receptor antagonists (MRAs) 2 open · Antiandrogens 1 open · Estrogens 3

Coming up

0phase 3 studies under way
2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Who these studies take

Of the 15 Hyperandrogenism studies recruiting now, 1 (7%) set no upper age limit and 14 (93%) stop at 75 or younger. 8 (53%) take children under 18. 13 (87%) are for women only and 0 (0%) for men only; 10 (67%) take healthy volunteers.

Recruiting studies that take each age, of 15
AgeWomenMen
106 (40%)1 (7%)
188 (53%)2 (13%)
307 (47%)1 (7%)
407 (47%)1 (7%)
502 (13%)0 (0%)
652 (13%)0 (0%)
751 (7%)0 (0%)
851 (7%)0 (0%)

Across all 81 studies, recruiting or not: 90% stop at 75 or younger and 89% at 65; 36% take children; 90% are for women only and 0% for men only; 42% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hyperandrogenism studies take

Of 12 interventional studies with no phase under Hyperandrogenism, half reached primary completion within 13 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase13 mo9–65 · 12 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Results posted1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 81. Browse all 81 → or search them.